The ATP-sensitive potassium channel (KATP) serves to couple the metabolic status of the cell to its electrical activity (Ashcroft & Rorsman, 1989) . One of the defining characteristics of this channel is that its open probability is decreased by intracellular ATP and enhanced by Mg¥ nucleotides, like MgADP. KATP channels are also blocked by sulphonylurea drugs, such as glibenclamide and tolbutamide, and activated by K¤ channel openers, such as diazoxide (Z unckler et al. 1988b). The â_cell KATP channel is a tightly associated heterooctameric complex of an inwardly rectifying potassium channel (Kir6.2) and a regulatory subunit, the sulphonylurea receptor (SUR1) (Inagaki et al. 1995; Sakura et al. 1995; Aguilar-Bryan et al. 1995; Clement et al. 1997; Inagaki et al. 1997; Shyng & Nichols, 1997) . Truncation of 26 amino acids from the C-terminus of Kir6.2 permits functional expression of this subunit in the absence of SUR1. Studies of this truncated subunit (Kir6.2ÄC26) have clearly demonstrated that Kir6.2 forms the pore of the channel and that it is inhibited by ATP, whereas SUR1 confers the stimulatory effects of MgADP and the K¤ channel opener diazoxide, as well as the characteristic highaffinity block by sulphonylureas Babenko et al. 1998 ). Kir6.2ÄC26, in the absence of SUR1, can also be inhibited by high concentrations of sulphonylureas but this subunit is at least three orders of magnitude less sensitive than the high-affinity sulphonylurea binding site on SUR1 (Gribble et al. 1997b) . SUR1 is able to 'enhance' or 'sensitize' the direct block of Kir6.2 by ATP, although the precise mechanism by which this occurs is as yet unresolved Trapp et al. 1998; Koster et al. 1999) . Thus SUR1 plays a key role in determining the ATP sensitivity of Kir6.2, as well as transducing the effects of high-affinity sulphonylurea binding into the closure of the 1. ATP-sensitive potassium (KATP) channels are composed of pore-forming Kir6.2 and regulatory SUR subunits. ATP inhibits the channel by interacting with Kir6.2, while sulphonylureas block channel activity by interaction with a high-affinity site on SUR1 and a low-affinity site on Kir6.2. MgADP and diazoxide interact with SUR1 to promote channel activity. 2. We examined the effect of N-terminal deletions of Kir6.2 on the channel open probability, ATP sensitivity and sulphonylurea sensitivity by recording macroscopic currents in membrane patches excised from Xenopus oocytes expressing wild-type or mutant Kir6.2ÏSUR1. 3. A 14 amino acid N-terminal deletion (ÄN14) did not affect the gating, ATP sensitivity or tolbutamide block of a truncated isoform of Kir6.2, Kir6.2ÄC26, expressed in the absence of SUR1. Thus, the N-terminal deletion does not alter the intrinsic properties of Kir6.2. 4. When Kir6.2ÄN14 was coexpressed with SUR1, the resulting KATP channels had a higher open probability (Pï = 0·7) and a lower ATP sensitivity (Ké = 196 ìÒ) than wild-type (Kir6.2ÏSUR1) channels (Pï = 0·32, Ké = 28 ìÒ). High-affinity tolbutamide block was also abolished. 5. Truncation of five or nine amino acids from the N-terminus of Kir6.2 also enhanced the open probability, and reduced both the ATP sensitivity and the fraction of high-affinity tolbutamide block, although to a lesser extent than for the ÄN14 deletion. Site-directed mutagenesis suggests that hydrophobic residues in Kir6.2 may be involved in this effect. 6. The reduced ATP sensitivity of Kir6.2ÄN14 may be explained by the increased Pï. However, when the Pï was decreased (by ATP), tolbutamide was unable to block Kir6.2ÄN14ÏSUR1-K719A,K1385M currents, despite the fact that the drug inhibited Kir6.2-C166SÏSUR1-K719A,K1385M currents (which in the absence of ATP have a Pï of > 0·8 and are not blocked by tolbutamide). Thus the N-terminus of Kir6.2 may be involved in coupling sulphonylurea binding to SUR1 to closure of the Kir6.2 pore.
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METHODS
Electrophysiology. Patch pipettes were pulled from thick-walled glass and had resistances of 250-500 kÙ when filled with pipette solution. Macroscopic currents were recorded from giant excised inside-out patches at a holding potential of 0 mV and at 20-24°C (Gribble et al. 1997a ). Currents were evoked by repetitive 3 s voltage ramps from −110 to +100 mV and recorded using an EPC7 patchclamp amplifier (List Electronic). They were filtered at 5 kHz and stored on digital audiotape. Currents were subsequently filtered at 0·5 kHz, digitized at 1 kHz using a Digidata 1200 interface and analysed using pCLAMP software (Axon Instruments). Singlechannel currents were recorded from small inside-out patches, filtered at 1 kHz and sampled at 3 kHz. 
Data analysis
The slope conductance was measured by fitting a straight line to the current-voltage relationship between −20 and −100 mV: the average of five consecutive ramps was calculated in each solution. ATP dose-response relationships were measured by alternating the control solution with a test ATP concentration. The conductance (G) was then expressed as a fraction of the mean of the value obtained in the control solution before and after exposure to ATP (Gc). Dose-response curves were fitted to the Hill equation:
where [ATP] is the ATP concentration, Ké is the concentration at which inhibition is half-maximal and h is the slope factor (Hill coefficient).
Tolbutamide dose-response curves were fitted to the following equation (Gribble et al. 1997a ): GÏGc = xy, (2) where x is a term describing the high-affinity site and y a term describing the low-affinity site.
(
where [Tolb] is the tolbutamide concentration; Ki1 and Ki2 are the tolbutamide concentrations at which inhibition is half-maximal at the high-and low-affinity sites, respectively; h1, h2 are the Hill coefficients (slope factors) for the high-and low-affinity sites, respectively; and L is the fractional conductance remaining when all of the high-affinity inhibitory sites are occupied. Single-channel currents were analysed using a combination of pCLAMP and in-house software written by Dr P. A. Smith (Oxford University). Single-channel current amplitudes were calculated from an all-points amplitude histogram. Channel activity (NPï) was measured as the mean patch current divided by the single-channel current amplitude, for segments of the current records of •1 min duration. Open probability (Pï) was calculated from NPïÏN, where N is the number of channels in the patch and was estimated from the maximum number of superimposed events. Data are given as means ± 1 s.e.m., and the symbols in the figures indicate the mean and the vertical bars indicate 1 s.e.m. (where this is larger than the symbol).
RESULTS ATP sensitivity Figure 1A shows that deletion of the first 14 amino acids from the N-terminus did not affect the ATP sensitivity of Kir6.2ÄC26. Half-maximal inhibition (Ké) of Kir6.2ÄC26-ÄN14 was produced by 109 ± 8 ìÒ ATP (n = 7), while a Ké of 106 ± 4 ìÒ (n = 7) was found for Kir6.2ÄC26. Coexpression of SUR1 with Kir6.2 enhances the channel ATP sensitivity, by a mechanism that is not yet clear . Figure 1B shows that this effect was impaired when the N-terminus of Kir6.2 is truncated: the Ké for ATP block of Kir6.2ÄN14ÏSUR1 currents was 196 ± 17 ìÒ (n = 10) compared with 28 ± 5 ìÒ (n = 5) for Kir6.2ÏSUR1 currents. This suggests that the N-terminus of Kir6.2 may be involved in functionally coupling this subunit to SUR1. In addition to enhancing the ability of ATP to inhibit Kir6.2, SUR1 confers sensitivity to the stimulatory effects of MgADP and diazoxide, and to the inhibitory effects of sulphonylureas . Therefore, we examined whether the N-terminus of Kir6.2 is also involved in transducing the interaction of these agents with SUR1 into changes in the gating of Kir6.2.
Effects of K¤ channel activators
As shown in Fig. 2 ATP, as is found for the wild-type KATP channel (Kir6.2/ SUR1). Diazoxide increased both currents to approximately the same amplitude but, possibly because ATP blocks Kir6.2ÄN14/SUR1 currents less potently, the relative increase in current was smaller than for Kir6.2ÏSUR1. Likewise, MgADP did not enhance Kir6.2ÄN14ÏSUR1 currents to the same extent as wild-type currents.
Sulphonylurea block
Tolbutamide interacts with a low-affinity site on Kir6.2 and a high-affinity site on SUR1 (Gribble et al. 1997b ). Truncation of the N-terminus did not alter the low-affinity block of Kir6.2 (Fig. 3) . When expressed in the absence of SUR1, the Ké for tolbutamide inhibition was 1·7 mÒ for Kir6.2ÄC36 (Gribble et al. 1997b ) and 2·0 ± 0·1 mÒ (n = 5) for Kir6.2ÄC26-ÄN14. This indicates that the first 14 amino acids of the N-terminus do not form part of the low-affinity site for tolbutamide on Kir6.2. Truncation of the N-terminus profoundly affects the ability of SUR1 to cause high-affinity inhibition of Kir6.2. As previously reported (Gribble et al. 1997b ), when SUR1 is coexpressed with Kir6.2 the dose-response curve for tolbutamide block is best fitted with two binding sites (Fig. 4) . In contrast to the wild-type KATP channel, only a single low-affinity site was observed for Kir6.2ÄN14ÏSUR1 currents. The Ké of this low-affinity site (2·6 ± 0·2 mÒ, n = 5) was similar to that of wild-type KATP channels (2·4 ± 0·1 mÒ, n = 6) and of Kir6.2ÄC36 (Gribble et al. 1997b) , indicating that it resides on Kir6.2. The Ké of the high-affinity site measured for Kir6.2ÏSUR1 was 1·4 ± 0·4 ìÒ (n = 6), a value similar to that previously reported (Gribble et al. 1997b ). We next examined whether the N-terminus of Kir6.2 is also concerned in coupling this subunit to SUR2A, a sulphonylurea receptor that shares 68% sequence identity with SUR1 (Inagaki et al. 1996) . Although Kir6.2ÏSUR2A currents do not show high-affinity inhibition by tolbutamide, they are blocked by glibenclamide with a potency similar to that of SUR1 (Gribble et al. 1998b ). Figure 5 shows that neither Kir6.2ÄN14ÏSUR1 nor Kir6.2ÄN14ÏSUR2A currents were blocked by glibenclamide at a concentration (100 nÒ) sufficient to cause maximal high-affinity inhibition of wild-type KATP channels. Thus an intact N-terminus of Kir6.2 is required for the inhibitory effect of both tolbutamide and glibenclamide, and SUR1 and SUR2A transduce the effects of sulphonylureas by a mechanism that involves common elements.
Mutations that affect coupling
To localize further residues within the N-terminus of Kir6.2 involved in coupling to SUR1, we made a number of additional truncations and mutations within this region. Deletion of residues 2-5 (ÄN5) or 2-9 (ÄN9) caused a progressive reduction in the amount of high-affinity tolbutamide inhibition (Fig. 6) . The maximal inhibition produced at the high-affinity site was 54% for wild-type KATP channels: this decreased to 38%, 25% and was finally completely abolished when the N-terminus of Kir6.2 was truncated by 5, 9 and 14 residues, respectively (Table 1) . There was also a small shift in the Ké for the high-affinity site, but the Hill coefficient remained unchanged (Table 1 ). Figure 7 shows the extent of block produced by 100 ìÒ tolbutamide for wild-type KATP currents, for the N_terminal truncations and for a number of mutations in the N-terminus of Kir6.2. No single mutation was sufficient to decrease tolbutamide block to that observed for Kir6.2ÄN14/SUR1: rather, the results suggest the involvement of a number of residues. Neutralization of the Kir6.2ÏSUR1 currents (1, n = 6) were fitted with eqn (1) and Kir6.2ÄN14ÏSUR1 currents (6, n = 5) were fitted with eqn (4) using the parameters given in Table 1 . charged residues K5, E10 and E11 did not significantly alter the extent of tolbutamide block, suggesting that these amino acids do not interact with SUR1. Neutralization of the arginine at position 4, however, reduced the extent of block to that found for the ÄN5 truncation: thus R4 may be involved in functional interaction with SUR1. Hydrophobic interactions may also be important, since L2A, and the combination of V13N and L14N, also reduced tolbutamide inhibition. Furthermore, tolbutamide block was abolished when residues 7, 8, 13 and 14 were simultaneously mutated to asparagine. However, since multiple mutations may destroy the local structure of the protein, the precise involvement of these hydrophobic residues is hard to assess.
Single-channel currents
One mechanism by which truncation of the N-terminus may alter the channel ATP and tolbutamide sensitivity in the presence of SUR1 is by impairing the ability of the channel to close (Shyng et al. 1997a; Tucker et al. 1998) . No difference was observed between the single-channel kinetics of Kir6.2ÄC26 and Kir6.2ÄC26-ÄN14 (Fig. 8, Table 2 ), indicating that the intrinsic gating of the channel is unaffected by removal of residues 2-14. The ability of SUR1 to enhance the open probability of Kir6.2 (Proks & Ashcroft, 1997) , however, was much greater when the N-terminus of Kir6.2 was truncated. As Fig. 8 and Table 2 Relationship between tolbutamide concentration and the macroscopic KATP conductance, expressed as a fraction of its amplitude in the absence of the drug. Kir6.2ÏSUR1 (1, n = 6), Kir6.2ÄN5ÏSUR1 (þ, n = 6) and Kir6.2ÄN9ÏSUR1 (3, n = 4) currents were fitted with eqn (1). Kir6.2ÄN14ÏSUR1 currents (6, n = 5) were fitted with eqn (4). The parameters used to fit the data are given in Table 1 .
--------------------------------------------------------------------------------------------Table 1. Tolbutamide block of KATP channels ----------------------------------------------
Clone* Ki1 h1 Ki2 h2 L n (ìÒ) (
mÒ) ----------------------------------------------
Kir6.2 1·42 ± 0·35 0·92 ± 0·06 2·40 ± 0·1 1·20 ± 0·1 0·46 ± 0·03 6 Kir6.2ÄN5 6·99 ± 2·02 1·01 ± 0·03 2·19 ± 0·33 1·45 ± 0·14 0·62 ± 0·03 6 Kir6.2ÄN9 22·52 ± 5·56 0·99 ± 0·01 2·24 ± 0·35 1·37 ± 0·09 0·75 ± 0·02 4 Kir6.2ÄN14 --2·56 ± 0·17 1·34 ± 0·05 -5 ----------------------------------------------*All coexpressed with SUR1. Data were fitted with a two-site model for tolbutamide inhibition (eqn (2)). Ki, tolbutamide concentration producing half-maximal block; h, Hill coefficient; L, maximum level of block produced by the high-affinity site. Table 2 . ATP block of KATP channels
Kir6.2ÄC36 106 ± 4 1·2 ± 0·1 7 0·11 ± 0·03 4 Kir6.2ÄC26-ÄN14 109 ± 8 0·9 ± 0·1 7 0·10 ± 0·02 4 With SUR1
Kir6.2 28 ± 5 1·0 ± 0·01 5 0·32 ± 0·10 4 Kir6.2ÄN5 50 ± 10 1·0 ± 0·1 5 0·44 ± 0·12 4 Kir6.2ÄN9 96 ± 26 1·0 ± 0·1 6 0·61 ± 0·08 4 Kir6.2ÄN14
± 17 1·2 ± 0·1 10 0·70 ± 0·09 4 ----------------------------------------------
Ki, ATP concentration producing half-maximal block; h, Hill coefficient; Po, open probability.
--------------------------------------------------------------------------------------------
coexpressed with SUR1, the open probability was greatly increased: the mean Pï was 0·32 for the wild-type KATP channel, but rose to 0·44 for Kir6.2ÄN5ÏSUR1, 0·61 for Kir6.2ÄN9ÏSUR1 and 0·70 for Kir6.2ÄN14ÏSUR1. There was also a clear correlation between the increase in Pï and that in the Ké for ATP inhibition (Table 2) . Thus it seems likely that the reduced ATP sensitivity is a consequence of the altered gating kinetics.
How do N-terminal deletions alter tolbutamide sensitivity?
We next explored whether the reduced sulphonylurea block of Kir6.2ÄN14ÏSUR1 is also merely a consequence of the enhanced channel open probability. One way to test this idea would be to decrease Pï by some independent means and then examine whether tolbutamide inhibition is affected. If the reduced sulphonylurea sensitivity of Kir6.2ÄN14/ SUR1 results only from its altered kinetics, we would expect tolbutamide to block the channel when the Pï was reduced prior to drug application: conversely, we predict that tolbutamide block would be independent of Pï if deletion of the N-terminus of Kir6.2 impairs the mechanism by which sulphonylurea binding to SUR1 is translated into pore closure. The simplest way to reduce the Pï of the KATP channel is to apply ATP. Figure 9Aa shows that tolbutamide blocked Kir6.2ÄN14ÏSUR1 currents when applied in the presence of 100 ìÒ ATP. This result requires careful interpretation, however, because of the interaction between Mg-nucleotides and sulphonylureas (Z unkler et al. 1988b; Gribble et al. 1997b) . Like MgADP, MgATP interacts with the KATP channel at two sites, one that induces channel inhibition (on Kir6.2) and one that causes channel activation (on SUR1) (Gribble et al. 1998a ). The overall action of MgATP is therefore a balance between these two opposing effects. It has been previously shown that tolbutamide abolishes the stimulatory action of MgADP, whilst leaving the inhibitory effect of the nucleotide on Kir6.2 intact (Gribble et al. 1997b) . As a consequence, the extent of sulphonylurea block is greater when MgADP is present, because it results from the combined actions of MgADP and tolbutamide. Mutation of the Walker A lysines of SUR1 prevents MgATP binding (Ueda et al. 1997) and Mg-nucleotide stimulation of channel activity (Gribble et al. 1997b; Shyng et al. 1997b; Trapp et al. 1998) . Figure 9Ab shows that the ability of tolbutamide to block the channel in the presence of MgATP was also abolished when both Walker A lysines were mutated (SUR1-K719A,K1385M, abbreviated SUR1-KAKM). This suggests that tolbutamide simply interferes with the stimulatory action of MgATP on Kir6.2ÄN14ÏSUR1 currents but has no direct blocking effect itself. When SUR1-KAKM is coexpressed with full-length Kir6.2, rather than Kir6.2ÄN14, tolbutamide causes channel inhibition in the absence of ATP (Gribble et al. 1997b) . To confirm that this is also the case in the presence of ATP, we used a mutant form of Kir6.2 (Kir6.2-R50E) which is blocked by ATP to a similar extent as Kir6.2ÄC26-ÄN14 (Proks et al. 1999) . This is because both the wild-type channel and Kir6.2ÏSUR1-KAKM are highly sensitive to ATP and the stimulatory effect of MgATP is not observed at low ATP concentrations (Gribble et al. 1998a) . As Fig. 9Ac shows, when Kir6.2-R50E and SUR1 were coexpressed, the resulting channel was not inhibited by 100 ìÒ ATP: indeed in some patches, as shown here, the channel was actually activated. This may be attributed to the stimulatory effect of MgATP mediated by the nucleotide binding domains of SUR1, because ATP was an effective inhibitor of the channel when the Walker A lysines in both NBDs were mutated (Fig. 9Ad) . Addition of tolbutamide in the presence of ATP produced a much more profound block Effects of SUR1 on Kir6. of Kir6.2-R50EÏSUR1 than was observed for Kir6.2ÄN14/ SUR1. Moreover, the drug remained able to block the channel when the stimulatory effect of MgATP was abolished by coexpression of Kir6.2-R50E with SUR1-KAKM (Fig. 9Ad) , in marked contrast to the lack of tolbutamide effect on Kir6.2ÄN14ÏSUR1-KAKM (Fig. 9Ab) . Taken together these results suggest that the ability of tolbutamide to uncouple the potentiatory effect of MgATP is not impaired by deletion of the N-terminus of Kir6.2. They further argue that the loss of tolbutamide block (most evident in the absence of nucleotide) involves a functional uncoupling of Kir6.2ÄN14 from SUR1, rather than being simply a secondary consequence of the enhanced Pï. To confirm this hypothesis, we used a mutant form of Kir6.2 that shows a markedly enhanced open probability. Mutation of cysteine 166 to serine (C166S) increases the Pï to 0·8, and concomitantly reduces the ATP sensitivity and abolishes inhibition by 0·1 mÒ tolbutamide . Figure 10A demonstrates that when the Pï of Kir6.2-C166SÏSUR1-KAKM was decreased to 50% by addition of ATP, 100 ìÒ tolbutamide caused significant inhibition of the current. In contrast, Kir6.2ÄN14ÏSUR1-KAKM currents were unaffected when the Pï was reduced. Mean data for the effect of tolbutamide at different ATP concentrations are given in Fig. 10B , and show that as the ATP concentration was increased, tolbutamide block of Kir6.2-C166SÏSUR1-KAKM was enhanced, while the drug continued to remain ineffective on Kir6.2ÄN14ÏSUR1-KAKM. Indeed, there was a reciprocal correlation between the extent of ATP block and that of tolbutamide inhibition in the presence of ATP for Kir6.2-C166SÏSUR1-KAKM, but not for Kir6.2ÄN14ÏSUR1-KAKM (Fig. 10C) . These data provide additional support for the idea that the lack of tolbutamide sensitivity of Kir6.2ÄN14ÏSUR1 is not the result of the enhanced Pï.
DISCUSSION
Our results show that partial deletion of the N-terminus of Kir6.2 has no effect on the intrinsic properties of Kir6.2, but influences KATP channel behaviour when Kir6.2 is coexpressed with SUR1. In particular, the open probability is enhanced, the sensitivity to the inhibitory effects of ATP and sulphonylureas is decreased and there is a reduction in the stimulatory action of diazoxide and MgADP. These data argue that the first 14 amino acids of Kir6.2 are involved in functional coupling to SUR1.
Gating
The open probability of Kir6.2ÄC26 is not affected by N_terminal deletions of up to 14 amino acids, indicating that these residues are not involved in the intrinsic gating of the Kir6.2 subunit. When wild-type Kir6.2 is coexpressed with SUR1, however, the open probability (Pï) of the KATP channel is enhanced -from a Pï of •0·1 to •0·3 (Proks & Ashcroft, 1997;  Table 2 ). The effect of SUR1 is magnified if between 5 and 14 residues are deleted from the N-terminus of Kir6.2, the Pï increasing in parallel with the length of the deletion. These data argue that the N-terminus of Kir6.2 may exert a negative effect on the ability of SUR1 to promote KATP channel activity. They also demonstrate that the ability of SUR1 to enhance the Pï (Proks & Ashcroft, 1997) cannot involve the first 14 residues of Kir6.2. Finally, our results raise the possibility that SUR1 may physically interact with the N-terminus of Kir6.2 to influence channel gating.
ATP sensitivity
There is accumulating evidence that ATP interacts with Kir6.2 to mediate KATP channel inhibition. This derives from the observations that a C-terminally truncated form of Kir6.2 (Kir6.2ÄC), expressed in the absence of SUR1, is blocked by ATP , that mutations within Kir6.2 affect the channel ATP sensitivity (Shyng et al. 1997a; Tucker et al. 1997 Tucker et al. , 1998 Drain et al. 1998) , and that Kir6.2 can be photo-affinity labelled with 8-azido-[ 32 P]ATP (Tanabe et al. 1999) . The results presented here demonstrate that the first 14 residues of Kir6.2 are not involved in ATP binding since deletion of these residues was without effect on ATP inhibition. A marked decrease in ATP sensitivity was observed when Kir6.2ÄN14 was coexpressed with SUR1. A similar finding has been reported for N-terminal truncations of 10-30 residues by others (Koster et al. 1999 ). Although we cannot exclude a direct involvement of the N-terminus of Kir6. the mechanism by which SUR1 enhances the ATP sensitivity of the KATP channel , we favour the idea that the decrease in ATP sensitivity of Kir6.2ÄN14ÏSUR1 is a secondary consequence of the reduced channel open probability. It has been shown that mutations which increase Pï also increase the Ké for ATP inhibition (Shyng et al. 1997a; Trapp et al. 1998 ). Our results demonstrate that there is a reciprocal increase in Pï and a decrease in ATP sensitivity for N-terminal truncations of different length. Thus the reduced efficacy of ATP may be an indirect result F. Reimann, S. J. Tucker, P. Proks and F. M. Ashcroft of the altered gating kinetics. A similar conclusion was reached by Koster et al. (1999) .
Nucleotide activation
Our results argue that deletion of the N-terminus of Kir6.2 does not alter the ability of MgADP or MgATPÏdiazoxide to enhance channel activity. Although the percentage increase in channel activity is less for Kir6.2ÄN14ÏSUR1 than for wildtype channels, the final current amplitude in the presence of the nucleotide is similar (or even enhanced). Since the channel has an upper limit of activity (Pï 0·9), the smaller increase in current observed for Kir6.2ÄN14ÏSUR1 is probably an inevitable consequence of the enhanced basal Pï.
Tolbutamide modulation of MgADP sensitivity
The ability of tolbutamide to abolish the stimulatory effects of MgATP was unaffected by deletion of the first 14 residues of Kir6.2. This result indicates that tolbutamide binding to SUR1 is unaffected by the deletion of the N_terminus of Kir6.2. It also indicates that the distal N_terminus is not required for this action of tolbutamide. Sulphonylureas might interfere with the potentiatory effects of Mg-nucleotides either by reducing nucleotide binding (to the NBDs of SUR1) or by preventing the translation of binding into channel activation. Because glibenclamide is able to block the co-operative binding of MgATP and MgADP to SUR1 , the former explanation seems more likely. The fact that removal of the N-terminus of Kir6.2 does not affect the ability of tolbutamide to inhibit MgADP activation is consistent with this idea.
Tolbutamide sensitivity
Removal of the first 14 residues of Kir6.2 did not alter the low-affinity block by tolbutamide, indicating that these amino acids do not contribute to the low-affinity binding site on Kir6.2. When Kir6.2ÄN14 was coexpressed with either SUR1 or SUR2A, however, high-affinity inhibition by sulphonylureas was completely abolished. Indeed, truncation of the N-terminus of Kir6.2 by as few as five amino acids greatly decreased the amount of block. There is good evidence that the high-affinity sulphonylurea binding site lies on SUR Tucker et al. 1997) . It therefore seems unlikely that N-terminal truncations of Kir6.2 influence the affinity of the sulphonylurea binding site on SUR. This idea is supported by the fact that tolbutamide is still able to abolish the stimulatory effects of Mg-nucleotides. We have considered two possible mechanisms by which N_terminal deletion of Kir6.2 might affect the efficacy of sulphonylurea inhibition. First, it may be a secondary consequence of the greater open probability of Kir6.2ÄN14/ SUR1 channels; second, it may result because the N_terminus is involved in transducing sulphonylurea binding to SUR1 into closure of the pore of Kir6.2. It is undeniable that a reduction of the channel open probability will concomitantly decrease sulphonylurea sensitivity: as previously described, Kir6.2-C166SÏSUR1 channels have an open probability •4-fold greater than wild-type and are unaffected by 100 ìÒ tolbutamide, a concentration specific for the high-affinity site on SUR1 . Thus the enhanced Pï of Kir6.2ÄN14ÏSUR1 may be expected to reduce sulphonylurea inhibition. Our results show, however, that this effect masks a more interesting phenomenon. When the Pï is lowered by other means, tolbutamide is still unable to block Kir6.2ÄN14ÏSUR1 currents, despite causing marked inhibition of Kir6.2-C166SÏSUR1 channels. We therefore conclude that the N-terminus of Kir6.2 is involved in coupling sulphonylurea binding to SUR1 into closure of the Kir6.2 pore. Whether this results from a direct physical interaction of the N-terminus of Kir6.2 with SUR1, or whether it involves an allosteric interaction between the two subunits, will require biochemical investigation.
